Folate status and neural tube defects.
Periconceptional folic acid supplementation prevents approximately 70% of neural tube defects (NTDs). While most women carrying affected fetuses do not have deficient blood folate levels, the risk of having an NTD affected child is inversely correlated with pregnancy red cell folate levels. Current research is focused on the discovery of genetic abnormalities in folate related enzymes which might explain the role of folate in NTD prevention. The first candidate gene to emerge was the C677T variant of 5,10-methylenetetrahydrofolate reductase. Normal subjects who are homozygous for the mutation (TT) have red cell folate status some 20% lower than expected. It is now established that the prevalence of the TT genotype is significantly higher among spina bifida cases and their parents. Nevertheless, our studies show that the variant does not account for the reduced blood folate levels in many NTD affected mothers. We conclude that low maternal folate status may in itself be the most important risk factor for NTDs and that food fortification may be the only population strategy of benefit in the effort to eliminate NTDs.
Molloy
A M
AM
Department of Clinical Medicine, Trinity College Dublin, Ireland.
Mills
J L
JL
Kirke
P N
PN
Weir
D G
DG
Scott
J M
JM
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D019587:Dietary Supplements; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D005494:Folic Acid Deficiency / Q000097:blood / Q000235:genetics*; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009436:Neural Tube Defects / Q000235:genetics* / Q000517:prevention & control; D010088:Oxidoreductases / Q000172:deficiency / Q000235:genetics*; D017354:Point Mutation; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood; D016135:Spinal Dysraphism / Q000235:genetics
D005492:Folic Acid; D010088:Oxidoreductases; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D042965:Methylenetetrahydrofolate Reductase (NADPH2)